scispace - formally typeset
D

David I. Wasserman

Researcher at University of Guelph

Publications -  10
Citations -  196

David I. Wasserman is an academic researcher from University of Guelph. The author has contributed to research in topics: Rostromedial tegmental nucleus & Ventral tegmental area. The author has an hindex of 6, co-authored 10 publications receiving 148 citations. Previous affiliations of David I. Wasserman include University of Toronto & University of Western Ontario.

Papers
More filters
Journal ArticleDOI

Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

TL;DR: A circuit model that links VTA and RMTg GABA with LDTg and PPTg neurons critical for DA‐dependent opioid effects in drug‐naïve rodents is proposed and hypothesized to lead to arousing and rewarding effects through disinhibition of VTA DA neurons.
Journal ArticleDOI

MouseBytes, an open-access high-throughput pipeline and database for rodent touchscreen-based cognitive assessment.

TL;DR: An integration of touchscreen cognitive testing with an open-access database public repository, as well as a Web platform for knowledge dissemination, envision that these new platforms will enhance sharing of protocols, data availability and transparency, allowing meta-analysis and reuse of mouse cognitive data to increase the replicability/reproducibility of datasets.
Journal ArticleDOI

Dopamine receptor D2 deficiency reduces mouse pup ultrasonic vocalizations and maternal responsiveness

TL;DR: The finding that exposure to USV‐emitting pups increased plasma prolactin levels in WT dams but not in D2R KO dams, and KO dams showed delayed pup retrieval and nest building further support the role of D 2R signalling in maternal care.
Journal ArticleDOI

Cholinergic control of morphine‐induced locomotion in rostromedial tegmental nucleus versus ventral tegmental area sites

TL;DR: M5 muscarinic acetylcholine receptors expressed on ventral tegmental dopamine neurons are needed for opioid activation of DA outputs and decreasing morphine‐induced locomotion was decreased by M5 receptor gene expression in RMTg GABA neurons that directly inhibit VTA DA neurons.
Journal ArticleDOI

Muscarinic control of rostromedial tegmental nucleus GABA neurons and morphine-induced locomotion.

TL;DR: It is proposed that cholinergic inhibition of rostromedial tegmental GABA neurons via M4 muscarinic receptors facilitates opioid inhibition of the same neurons.